Our data fit well with other evidences linking ERRα expression to increased ability of aggressive breast cancer cells to form lung metastases [26] and ERRα knockdown to reduced migration and invasion of endometrial [27], gastric [28] and bladder cancer [29] and non-small cell lung carcinoma [30]. Here, ESRRA is linked to breast cancer.